In PCa, IGF2 seems to be particularly important during early phases of tumorigenesis, or when an advanced tumor is challenged through chemotherapy or androgen deprivation, while it may be less relevant in established tumors under ‘steady‐state’ conditions. Here, IGF2 is linked to posterior cortical atrophy.